CDTi Announces the Appointment of Lon E. Bell, Ph.D. to Its Board of Directors

Clean Diesel Technologies

, a cleantech emissions control company, announced today that Lon E. Bell, Ph.D.has been appointed to serve as an independent director on CDTi's Board of Directors. Dr. Bell, an experienced industry executive with a national reputation as an expert in the mass production of thermoelectric products, has been granted over 100 patents for his inventions. CDTi's Board of Directors unanimously elected Dr. Bell on June 17, 2013 to serve as a member of the Board until the next annual meeting of stockholders. Dr. Bell, 72, founded Gentherm, formerly Amerigon Inc., a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications in 1991. Dr. Bell most recently served as a consultant to Gentherm until December 2012. "We are very excited to have Dr. Bell join our Board of Directors," said Alexander Ellis, III, Chairman of the CDTi Board of Directors. "He is a highly accomplished executive with significant business acumen, technology and commercialization experience and first-hand understanding of the automotive industry, and will serve as a great resource for the Company as it further develops and extends its materials science technology platform into new markets. Our Board members look forward to the valuable perspective Dr. Bell will provide related to CDTi's strategy, operations and technology development as we remain focused on delivering value to CDTi's customers, employees and shareholders." "I'm delighted to join the Board of Directors of CDTi and particularly excited about contributing insight and guidance related to the Company's research and development activities," said Dr. Bell. "I believe CDTi's proprietary advanced low- and zero-platinum group metals catalyst technology represents an important new development and opportunity, and a disruptive materials science capability with potential applications in many industries." Dr. Bell has authored more than 20 publications in the areas of thermodynamics of thermoelectric systems, automotive crash sensors, and other electronic and electromechanical devices. Five of his inventions have gone into mass production and dominated their target markets. Since founding Gentherm, Dr. Bell has served many roles at the company, including Chief Technology Officer until December 2010, Director of Technology until 2000, Chairman and Chief Executive Officer until 1999, and President until 1997. Dr. Bell served as the Chief Executive Officer and President of BSST LLC, a subsidiary of Gentherm from September 2000 to December 2010. He served as a Director of Gentherm from 1991 to 2012. Previously, Dr. Bell co-founded Technar Incorporated, which developed and manufactured automotive components, and served as Technar's Chairman and President until selling majority ownership to TRW Inc. in 1986. Dr. Bell continued managing Technar, then known as TRW Technar, as its President until 1991. He co-founded Mahindra REVA Electric Vehicle Pvt Ltd in 1994 and serves as a Director. Currently in addition to CDTi, he serves on the boards of Clearsign Combustion, Mahindra-Reva, Ideal Power Converters, Inc., and Aura Systems Inc. Dr. Bell received a BSc. in Mathematics, an MSc. in Rocket Propulsion, and a Ph.D. in Mechanical Engineering from the California Institute of Technology. About CDTi CDTi is a vertically integrated global manufacturer and distributor of emissions control systems and products, focused on the heavy duty diesel and light duty vehicle markets. CDTi utilizes its proprietary patented Mixed Phase Catalyst (MPC®) technology, as well as its ARIS® selective catalytic reduction, Platinum Plus® fuel-borne catalyst, and other technologies to provide high-value sustainable solutions to reduce emissions, increase energy efficiency and lower the carbon intensity of on- and off-road engine applications. CDTi is headquartered in Ventura, California and currently has operations in the U.S., Canada, France, Japan and Sweden. For more information, please visit www.cdti.com.